**4. Conclusions**

EUS-E is a complementary tool for pancreatic disease assessment with a continuous endeavor to aid as a proper diagnosis method. While this method may not replace EUS tissue acquisition, it may be used as an additional method to help the decisionmaking process.

While strain EUS-E was the first technique used, with various results, the recent EUS-SWM in a pancreatic setting still requires more investigations. With only a few studies, and perhaps more to come in the next years, perhaps SWM will overcome the flaws of strain EUS-E and will be used more for pancreatic disease assessment.

Moreover, new software developments, such as artificial intelligence tools could also be an alternative, by enabling a more rapid diagnostic based on image analysis.

In conclusion, EUS-E might require more attention, because of its potential, and in combination with other methods, such as CEUS, may maximize the efforts for pancreatic disease management.
